⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9862148 | 1.00 | ADH1C (0.33) | — | |
| SCHEMBL614355 | 0.90 | — | — | |
| SCHEMBL9246549 | 0.88 | — | — | |
| SCHEMBL18731298 | 0.88 | — | — | |
| SCHEMBL13744577 | 0.88 | — | — | |
| SCHEMBL383574 | 0.87 | ADH1A (0.46) | — | |
| SCHEMBL24220857 | 0.86 | — | — | |
| SCHEMBL20245246 | 0.86 | — | — | |
| SCHEMBL9558234 | 0.86 | — | — | |
| SCHEMBL3490832 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050192279-A1 | Pyridazinones as antagonists of alpha4 integrins | JANSSEN PHARAMACEUTICA, N.V. (BE) | 2005-09-01 | — | — | US | claimed |
| CN-117858374-A | PCB (printed circuit board) hole plugging magnetic adhesive and PCB hole plugging process thereof | 景旺电子科技(珠海)有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20230322785-A1 | ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY | MERCK SHARP & DOHME LLC (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230109839-A1 | THERAPEUTIC AGENT FOR TAUOPATHIES | Sumitomo Pharma Co., Ltd. (JP) | 2023-04-13 | — | — | US | disclosed |
| US-20230033021-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN INTEGRIN INHIBITOR | GLAS USA LLC | 2023-02-02 | — | — | US | disclosed |
| WO-2022146027-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | 주식회사 비투에스바이오 | 2022-07-07 | — | — | WO | disclosed |
| US-10577346-B2 | Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2020-03-03 | — | — | US | disclosed |
| US-20190161468-A1 | BENZODICYCLOALKANE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2019-05-30 | — | — | US | disclosed |
| EP-2076558-B1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | DOW CORNING (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-2427425-B1 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS INC (US) | 2017-03-08 | — | — | EP | disclosed |
| CN-101528813-B | Composition comprising neopentasilane and method of preparing same | DOW CORNING INC | 2011-10-26 | — | — | CN | disclosed |
| US-20100323965-A1 | Thrombopoietin Mimetics | STATEGICS, INC. (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100176338-A1 | Composition Comprising Neopentasilane And Method Of Preparing Same | NATA SEMICONDUCTOR MATERIALS CO., LTD. (CN) | 2010-07-15 | — | — | US | disclosed |
| CN-101528813-A | Composition comprising neopentasilane and method of preparing same | DOW CORNING (US) | 2009-09-09 | — | — | CN | disclosed |
| EP-2076558-A1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | Dow Corning Corporation (US) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008051328-A1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | DOW CORNING CORPORATION (US) | 2008-05-02 | — | — | WO | disclosed |
| US-20070219210-A1 | Amidopyrazole Derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1698626-A1 | AMIDOPYRAZOLE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-09-06 | — | — | EP | disclosed |
| US-20050192279-A1 | Pyridazinones as antagonists of alpha4 integrins | JANSSEN PHARAMACEUTICA, N.V. (BE) | 2005-09-01 | — | — | US | disclosed |
| CN-1499972-A | Imidazolyl derivatives as corticotropin releasing factor inhibitors | ����˹�ж�-����˹˹������˾ | 2004-05-26 | — | — | CN | disclosed |